首页 > 最新文献

Hormone Molecular Biology and Clinical Investigation最新文献

英文 中文
The neuropharmacological and clinical effects of lutein: a systematic review. 叶黄素的神经药理学和临床效应:系统综述。
IF 1.1 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-23 DOI: 10.1515/hmbci-2024-0053
Atefeh Arab Firozjae, Mohammad Reza Shiran, Mohsen Rashidi

Objectives: Neurodegenerative diseases are defined by specific protein accumulation and anatomic vulnerability leading to neuronal loss. Some studies have shown that lutein may have an effect on neurodegenerative diseases. As most of the neurodegenerative diseases don't have certain cure and therapies focus on symptom control, Lutein may be a complementary treatment. Due to controversies in studies investigating lutein effect on neurodegenerative diseases, we decided to perform a systematic review on these studies.

Methods: A systematic search was carried out in the available databases. We used all MeSH terms and relevant keywords. Studies that reported relationship between lutein and any neurodegenerative disease were included.

Results: We found 278 studies. After removing duplicates, screening by titles and abstracts and excluding irrelevant papers, 17 articles were included in this study. Fourteen studies investigated Alzheimer's disease, 2 studies Parkinson's disease and 1 study Amyotrophic lateral sclerosis. 1/17 study found that high serum levels of lutein at baseline were associated with a lower risk of AD mortality and lutein effect on lipid profile have been investigated in 2/17 studies. Also, 1/17 study has been shown that high intake of lutein may reduce the risk of ALS progression.

Conclusions: 4/17 studies confirm that lutein can improve cognitive function. 8/17 studies demonstrate a reduction in the progression of AD, and 2/17 studies indicate an improvement in lipid profiles. However, some studies did not find any significant associations. Additionally, there is a limited number of studies investigating the effects of lutein on other neurodegenerative diseases.

目的:神经退行性疾病的定义是特定蛋白质的积累和解剖学上的脆弱性导致神经元的丧失。一些研究表明,叶黄素可能对神经退行性疾病有影响。由于大多数神经退行性疾病都没有明确的治疗方法,而治疗方法主要集中在症状控制上,叶黄素可能是一种辅助治疗方法。由于调查叶黄素对神经退行性疾病影响的研究存在争议,我们决定对这些研究进行系统性回顾:方法:我们在现有数据库中进行了系统检索。我们使用了所有 MeSH 术语和相关关键词。结果:我们发现了 278 项研究:我们找到了 278 项研究。结果:我们找到了 278 项研究,在去除重复研究、筛选标题和摘要并排除无关论文后,本研究纳入了 17 篇文章。14 项研究调查了阿尔茨海默病,2 项研究调查了帕金森病,1 项研究调查了肌萎缩侧索硬化症。17项研究中有1项研究发现,基线血清中叶黄素水平高与阿兹海默症死亡风险较低有关,17项研究中有2项研究调查了叶黄素对血脂的影响。此外,1/17 的研究表明,叶黄素的高摄入量可降低 ALS 的恶化风险:结论:4/17 项研究证实叶黄素可改善认知功能。结论:4/17 项研究证实叶黄素可改善认知功能,8/17 项研究表明叶黄素可减少注意力缺失症的进展,2/17 项研究表明叶黄素可改善血脂状况。不过,有些研究并未发现任何明显的关联。此外,调查叶黄素对其他神经退行性疾病影响的研究数量有限。
{"title":"The neuropharmacological and clinical effects of lutein: a systematic review.","authors":"Atefeh Arab Firozjae, Mohammad Reza Shiran, Mohsen Rashidi","doi":"10.1515/hmbci-2024-0053","DOIUrl":"https://doi.org/10.1515/hmbci-2024-0053","url":null,"abstract":"<p><strong>Objectives: </strong>Neurodegenerative diseases are defined by specific protein accumulation and anatomic vulnerability leading to neuronal loss. Some studies have shown that lutein may have an effect on neurodegenerative diseases. As most of the neurodegenerative diseases don't have certain cure and therapies focus on symptom control, Lutein may be a complementary treatment. Due to controversies in studies investigating lutein effect on neurodegenerative diseases, we decided to perform a systematic review on these studies.</p><p><strong>Methods: </strong>A systematic search was carried out in the available databases. We used all MeSH terms and relevant keywords. Studies that reported relationship between lutein and any neurodegenerative disease were included.</p><p><strong>Results: </strong>We found 278 studies. After removing duplicates, screening by titles and abstracts and excluding irrelevant papers, 17 articles were included in this study. Fourteen studies investigated Alzheimer's disease, 2 studies Parkinson's disease and 1 study Amyotrophic lateral sclerosis. 1/17 study found that high serum levels of lutein at baseline were associated with a lower risk of AD mortality and lutein effect on lipid profile have been investigated in 2/17 studies. Also, 1/17 study has been shown that high intake of lutein may reduce the risk of ALS progression.</p><p><strong>Conclusions: </strong>4/17 studies confirm that lutein can improve cognitive function. 8/17 studies demonstrate a reduction in the progression of AD, and 2/17 studies indicate an improvement in lipid profiles. However, some studies did not find any significant associations. Additionally, there is a limited number of studies investigating the effects of lutein on other neurodegenerative diseases.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142499455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of serum inhibin B and inhibin B/FSH ratio in the diagnosis of non-obstructive azoospermia and oligozoospermia. 评估血清抑制素 B 和抑制素 B/FSH 比率在诊断非梗阻性无精子症和少精子症中的作用。
IF 1.1 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-21 DOI: 10.1515/hmbci-2024-0054
Olaniru B Olumide, Adoga I Godwin, Nkereuwem S Etukudoh, Sulagna Dutta, Obeta M Uchejeso, Johnson O Titilayo, Isichei O Christian, Selowo T Temitope, Pallav Sengupta

Objectives: Infertility affects approximately 15 % of couples globally, with 50 % cases of male factor infertility. Precise assessment of spermatogenesis is essential for evaluating male infertility. Recent studies suggest serum inhibin B as a promising biomarker for testicular function. This study aims to evaluate the diagnostic utility of serum inhibin B in predicting male infertility, particularly focusing on its relationship with sperm count.

Methods: A cross-sectional study was conducted on 80 adult men (mean age 31.4 ± 6.89 years) presenting with infertility at gynecology and urology outpatient departments. Semen analysis was performed following WHO (2010) guidelines, and serum inhibin B levels were quantified. The correlation between serum inhibin B levels and sperm parameters was assessed using Pearson's correlation test. Receiver operating characteristic (ROC) curve analysis was employed to evaluate the diagnostic accuracy of serum inhibin B and the inhibin B/FSH ratio for non-obstructive azoospermia (NOA) and oligozoospermia.

Results: A significant positive correlation was observed between serum inhibin B and sperm count (r=0.94, p<0.001). ROC analysis demonstrated that the inhibin B/FSH ratio had the highest diagnostic accuracy for NOA and oligozoospermia (AUC=0.986), with sensitivity of 100 % and specificity of 91.67 %. Serum inhibin B alone also showed high diagnostic value (AUC=0.965 for NOA and 0.969 for oligozoospermia).

Conclusions: Serum inhibin B is a reliable biomarker for assessing male infertility, particularly in evaluating spermatogenic function. The inhibin B/FSH ratio provides superior diagnostic accuracy for NOA and oligozoospermia, offering valuable clinical utility in male infertility diagnosis.

目的:全球约有 15% 的夫妇患有不育症,其中 50% 为男性因素导致的不育症。精子发生的精确评估对于评估男性不育症至关重要。最近的研究表明,血清抑制素 B 是一种很有前途的睾丸功能生物标志物。本研究旨在评估血清抑制素 B 在预测男性不育症方面的诊断效用,尤其关注其与精子数量的关系:方法:对妇科和泌尿科门诊的 80 名不育症成年男性(平均年龄为 31.4 ± 6.89 岁)进行了横断面研究。根据世界卫生组织(2010 年)指南进行了精液分析,并对血清抑制素 B 水平进行了量化。血清抑制素 B 水平与精子参数之间的相关性采用皮尔逊相关性检验进行评估。采用接收操作特征曲线(ROC)分析评估血清抑制素 B 和抑制素 B/FSH 比值对非梗阻性无精子症(NOA)和少精子症的诊断准确性:结果:血清抑制素 B 与精子计数之间存在明显的正相关性(r=0.94,p):血清抑制素 B 是评估男性不育症的可靠生物标志物,尤其是在评估生精功能方面。抑制素 B/FSH 比值对无精子症和少精子症的诊断准确性更高,在男性不育诊断中具有宝贵的临床价值。
{"title":"Evaluation of serum inhibin B and inhibin B/FSH ratio in the diagnosis of non-obstructive azoospermia and oligozoospermia.","authors":"Olaniru B Olumide, Adoga I Godwin, Nkereuwem S Etukudoh, Sulagna Dutta, Obeta M Uchejeso, Johnson O Titilayo, Isichei O Christian, Selowo T Temitope, Pallav Sengupta","doi":"10.1515/hmbci-2024-0054","DOIUrl":"https://doi.org/10.1515/hmbci-2024-0054","url":null,"abstract":"<p><strong>Objectives: </strong>Infertility affects approximately 15 % of couples globally, with 50 % cases of male factor infertility. Precise assessment of spermatogenesis is essential for evaluating male infertility. Recent studies suggest serum inhibin B as a promising biomarker for testicular function. This study aims to evaluate the diagnostic utility of serum inhibin B in predicting male infertility, particularly focusing on its relationship with sperm count.</p><p><strong>Methods: </strong>A cross-sectional study was conducted on 80 adult men (mean age 31.4 ± 6.89 years) presenting with infertility at gynecology and urology outpatient departments. Semen analysis was performed following WHO (2010) guidelines, and serum inhibin B levels were quantified. The correlation between serum inhibin B levels and sperm parameters was assessed using Pearson's correlation test. Receiver operating characteristic (ROC) curve analysis was employed to evaluate the diagnostic accuracy of serum inhibin B and the inhibin B/FSH ratio for non-obstructive azoospermia (NOA) and oligozoospermia.</p><p><strong>Results: </strong>A significant positive correlation was observed between serum inhibin B and sperm count (r=0.94, p<0.001). ROC analysis demonstrated that the inhibin B/FSH ratio had the highest diagnostic accuracy for NOA and oligozoospermia (AUC=0.986), with sensitivity of 100 % and specificity of 91.67 %. Serum inhibin B alone also showed high diagnostic value (AUC=0.965 for NOA and 0.969 for oligozoospermia).</p><p><strong>Conclusions: </strong>Serum inhibin B is a reliable biomarker for assessing male infertility, particularly in evaluating spermatogenic function. The inhibin B/FSH ratio provides superior diagnostic accuracy for NOA and oligozoospermia, offering valuable clinical utility in male infertility diagnosis.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142464197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interpretation of TSH results can be improved by reference values fluctuating in time. 参考值随时间波动,可提高 TSH 结果的解释能力。
IF 1.1 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-01 DOI: 10.1515/hmbci-2024-0043
Joris R Delanghe, Jan Van Elslande, Maaike Godefroid, Marijn M Speeckaert, Thomas M Maenhout

Objectives: The secretion of thyroid stimulating hormone (thyrotropin, TSH), is characterized by a marked circadian rhythm. Plasma or serum TSH values are significantly lower in the afternoon and in the evening as compared to the early morning. As in clinical practice, blood sampling time shows an important variation, a reliable assessment of thyroid status is often not an easy task for the clinician. The biological variation of TSH plays a major role in the intra-individual variability of TSH results in serum or plasma. The observed intra-day variation largely exceeds the reported inter-vendor variation and the coefficient of variation of clinical TSH assays. Therefore, a mathematical solution was sought for correcting interpretation of TSH results for sampling time.

Methods: We have developed a cosinor model which allows to compensate TSH decision values for the fluctuating serum or plasma TSH concentrations throughout the day.

Results: The following mathematical function could be derived: corrected TSH cutoff_value (mIU/L)=0.40 + 0.24*cos(((π/12) *T) + 6) in which T represents the time (hours). This mathematical function can be easily implemented into a laboratory's informatics system and furthermore allows a better tailored diagnosis of (subclinical) hyperthyroidism, regardless the blood sampling time.

Conclusions: Implementing the corrected cut-off values result in a marked reduction of apparent (false positive) hyperthyroidism diagnosis, in particular in the afternoon.

目的:促甲状腺激素(TSH)的分泌有明显的昼夜节律。与清晨相比,下午和傍晚的血浆或血清促甲状腺激素值明显较低。在临床实践中,采血时间会出现很大的变化,因此对临床医生来说,可靠地评估甲状腺状态往往不是一件容易的事。促甲状腺激素的生物变异在血清或血浆中促甲状腺激素结果的个体内变异中起着重要作用。观察到的日内变异在很大程度上超过了报告的供应商间变异和临床 TSH 检测的变异系数。因此,我们正在寻求一种数学解决方案,以校正采样时间对 TSH 结果的解释:方法:我们建立了一个 cosinor 模型,该模型可以根据血清或血浆 TSH 浓度在一天中的波动对 TSH 决定值进行补偿:可以得出以下数学函数:校正 TSH 临界值(mIU/L)=0.40 + 0.24*cos(((π/12) *T)+ 6),其中 T 代表时间(小时)。这个数学函数可以很容易地应用到实验室的信息系统中,而且还能更好地诊断(亚临床)甲状腺功能亢进症,而不受采血时间的影响:结论:采用校正后的临界值可显著减少甲状腺功能亢进的明显(假阳性)诊断,尤其是在下午。
{"title":"Interpretation of TSH results can be improved by reference values fluctuating in time.","authors":"Joris R Delanghe, Jan Van Elslande, Maaike Godefroid, Marijn M Speeckaert, Thomas M Maenhout","doi":"10.1515/hmbci-2024-0043","DOIUrl":"https://doi.org/10.1515/hmbci-2024-0043","url":null,"abstract":"<p><strong>Objectives: </strong>The secretion of thyroid stimulating hormone (thyrotropin, TSH), is characterized by a marked circadian rhythm. Plasma or serum TSH values are significantly lower in the afternoon and in the evening as compared to the early morning. As in clinical practice, blood sampling time shows an important variation, a reliable assessment of thyroid status is often not an easy task for the clinician. The biological variation of TSH plays a major role in the intra-individual variability of TSH results in serum or plasma. The observed intra-day variation largely exceeds the reported inter-vendor variation and the coefficient of variation of clinical TSH assays. Therefore, a mathematical solution was sought for correcting interpretation of TSH results for sampling time.</p><p><strong>Methods: </strong>We have developed a cosinor model which allows to compensate TSH decision values for the fluctuating serum or plasma TSH concentrations throughout the day.</p><p><strong>Results: </strong>The following mathematical function could be derived: corrected TSH cutoff_value (mIU/L)=0.40 + 0.24*cos(((π/12) *T) + 6) in which T represents the time (hours). This mathematical function can be easily implemented into a laboratory's informatics system and furthermore allows a better tailored diagnosis of (subclinical) hyperthyroidism, regardless the blood sampling time.</p><p><strong>Conclusions: </strong>Implementing the corrected cut-off values result in a marked reduction of apparent (false positive) hyperthyroidism diagnosis, in particular in the afternoon.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142345817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between cerebrospinal fluid chitotriosidase level and amyotrophic lateral sclerosis: a systematic review. 脑脊液壳三糖苷酶水平与肌萎缩性脊髓侧索硬化症的关系:系统综述。
IF 1.1 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-01 DOI: 10.1515/hmbci-2024-0007
Zeinab Khorshidi, Iman Adibi, Majid Ghasemi

Introduction: One of the fatal and debilitating neurodegenerative diseases is amyotrophic lateral sclerosis (ALS). Increasing age is one of the risk factors of ALS. Considering that the elderly population in the world is increasing, it is very important to identify useful and effective diagnostic and treatment methods. The purpose of this systematic review is to determine the relationship between chitotriosidase (CHIT1) level and ALS disorder.

Content: Keywords "Amyotrophic Lateral Sclerosis", "Gehrig* Disease", "Charcot Disease", "Guam Disease", ALS, CHIT1 and chitotriosidase were searched in PubMed, Scopus, Web of Science and Science Direct databases without time limit on September 2023. Hundred twenty studies were obtained by searching, and finally, 14 studies were included in this study using the inclusion and exclusion criteria. In all 14 selected studies, the level of biomarker CHIT1 in the CSF of ALS patients was significantly higher than that of healthy control and disease control groups. But, in 8 studies that included 3 groups, no significant difference was observed between the CHIT1 levels in the two control groups. Six studies have reported the amount of CHIT1 level quantitatively. Among these 6 studies, in 5 studies CHIT1 level in disease control was higher than healthy control (not significant) and in only one study CHIT1 level was higher in healthy control compared to disease control (not significant).

Summary and outlook: In all 14 studies, a multifold increase in CHIT1 levels has been observed in patients compared to healthy and disease control groups. Therefore, based on the findings of the studies, this study confirms the relationship between CHIT1 increase and ALS disorder.

简介肌萎缩性脊髓侧索硬化症(ALS)是一种致命且使人衰弱的神经退行性疾病。年龄增长是 ALS 的风险因素之一。考虑到全球老年人口在不断增加,确定有用且有效的诊断和治疗方法非常重要。本系统综述旨在确定壳三糖苷酶(CHIT1)水平与 ALS 疾病之间的关系:关键词 "肌萎缩侧索硬化症"、"Gehrig*病"、"Charcot病"、"Guam病"、ALS、CHIT1和壳三糖苷酶,于2023年9月在PubMed、Scopus、Web of Science和Science Direct数据库中进行了无时间限制的检索。通过检索获得了 120 项研究,最后,根据纳入和排除标准,本研究纳入了 14 项研究。在所有入选的 14 项研究中,ALS 患者 CSF 中生物标志物 CHIT1 的水平明显高于健康对照组和疾病对照组。但在包含 3 组的 8 项研究中,未观察到两个对照组的 CHIT1 水平有明显差异。有 6 项研究定量报告了 CHIT1 的水平。在这 6 项研究中,有 5 项研究发现疾病对照组的 CHIT1 水平高于健康对照组(无显著性差异),只有一项研究发现健康对照组的 CHIT1 水平高于疾病对照组(无显著性差异):在所有 14 项研究中,与健康组和疾病对照组相比,患者的 CHIT1 水平增加了数倍。因此,根据这些研究结果,本研究证实了 CHIT1 增高与 ALS 疾病之间的关系。
{"title":"Association between cerebrospinal fluid chitotriosidase level and amyotrophic lateral sclerosis: a systematic review.","authors":"Zeinab Khorshidi, Iman Adibi, Majid Ghasemi","doi":"10.1515/hmbci-2024-0007","DOIUrl":"https://doi.org/10.1515/hmbci-2024-0007","url":null,"abstract":"<p><strong>Introduction: </strong>One of the fatal and debilitating neurodegenerative diseases is amyotrophic lateral sclerosis (ALS). Increasing age is one of the risk factors of ALS. Considering that the elderly population in the world is increasing, it is very important to identify useful and effective diagnostic and treatment methods. The purpose of this systematic review is to determine the relationship between chitotriosidase (CHIT1) level and ALS disorder.</p><p><strong>Content: </strong>Keywords \"Amyotrophic Lateral Sclerosis\", \"Gehrig* Disease\", \"Charcot Disease\", \"Guam Disease\", ALS, CHIT1 and chitotriosidase were searched in PubMed, Scopus, Web of Science and Science Direct databases without time limit on September 2023. Hundred twenty studies were obtained by searching, and finally, 14 studies were included in this study using the inclusion and exclusion criteria. In all 14 selected studies, the level of biomarker CHIT1 in the CSF of ALS patients was significantly higher than that of healthy control and disease control groups. But, in 8 studies that included 3 groups, no significant difference was observed between the CHIT1 levels in the two control groups. Six studies have reported the amount of CHIT1 level quantitatively. Among these 6 studies, in 5 studies CHIT1 level in disease control was higher than healthy control (not significant) and in only one study CHIT1 level was higher in healthy control compared to disease control (not significant).</p><p><strong>Summary and outlook: </strong>In all 14 studies, a multifold increase in CHIT1 levels has been observed in patients compared to healthy and disease control groups. Therefore, based on the findings of the studies, this study confirms the relationship between CHIT1 increase and ALS disorder.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142345816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The association of the basal TIMI flow, post-PCI TIMI flow and thrombus grade with HbA1c levels in non-diabetic patients with acute ST segment elevation myocardial infarction undergoing primary PCI. 接受初级 PCI 治疗的急性 ST 段抬高型心肌梗死非糖尿病患者的基础 TIMI 血流、PCI 后 TIMI 血流和血栓等级与 HbA1c 水平的关系。
IF 1.1 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-09-24 DOI: 10.1515/hmbci-2023-0072
Mina Doudkani Fard, Ahmad Separham, Ehsan Mamaghanizadeh, Yousef Faridvand, Vahid Toupchi Khosroshahi, Somayeh Sarvari

Objectives: The acute phase of ST-segment elevation myocardial infarction (STEMI), as determined by TIMI angiographic criteria, is influenced by various factors that impact the patient's clinical outcome. However, the modifiable risk factors of impaired TIMI flow (TIMI<3) and its effective treatment are not fully understood. Hyperglycemia may induce a pro thrombotic state and thus affect TIMI flow before or after PCI. This study investigates the correlation between hemoglobin A1c levels, TIMI flow grade, and thrombus grade in infarct-related arteries, assessing its predictive value in non-diabetic patients with STEMI.

Methods: The 265 patients selected based on the hemoglobin A1c level lower than 6.5 % and were divided into three groups based on HbA1c level. Comparison between three groups in terms of risk factors, troponin level, blood glucose level, lipid profile, kidney function, number of involved vessels, type of MI, left ventricular ejection fraction, TIMI flow before and after primary angioplasty, thrombus burden, complications and hospital mortality was made.

Results: With the increase in HbA1c level, the prevalence of TIMI 3 flow after primary PCI decreased. The prevalence of TIMI flow 2-3 before angioplasty also decreased with the increase in HbA1c level. Increased hemoglobin A1c was also significantly related to large thrombus burden (p=0.021). Morover, hemoglobin A1c remained an independent predictor of post-PCI TIMI flow and thrombus burden.

Conclusions: Elevated hemoglobin A1c is a predictor of TIMI flow less than 3 after primary PCI and high thrombus burden, in STEMI patients without a history of diabetes mellitus.

目标:根据 TIMI 血管造影标准,ST 段抬高型心肌梗死(STEMI)的急性期受多种因素影响,这些因素会影响患者的临床预后。然而,TIMI 血流受损的可改变风险因素(TIMIM 方法)并不存在:根据血红蛋白 A1c 水平低于 6.5 % 筛选出 265 名患者,并根据 HbA1c 水平将其分为三组。比较三组患者的危险因素、肌钙蛋白水平、血糖水平、血脂情况、肾功能、受累血管数量、心肌梗死类型、左室射血分数、一次血管成形术前后的 TIMI 流量、血栓负担、并发症和住院死亡率:结果:随着 HbA1c 水平的升高,初级 PCI 术后 TIMI 3 血流的发生率降低。血管成形术前 TIMI 2-3 血流的发生率也随着 HbA1c 水平的升高而降低。血红蛋白 A1c 的增加与大血栓负荷也有显著关系(P=0.021)。此外,血红蛋白A1c仍然是PCI术后TIMI血流和血栓负荷的独立预测因子:结论:对于无糖尿病史的 STEMI 患者,血红蛋白 A1c 升高是初级 PCI 后 TIMI 血流小于 3 和高血栓负荷的预测因素。
{"title":"The association of the basal TIMI flow, post-PCI TIMI flow and thrombus grade with HbA1c levels in non-diabetic patients with acute ST segment elevation myocardial infarction undergoing primary PCI.","authors":"Mina Doudkani Fard, Ahmad Separham, Ehsan Mamaghanizadeh, Yousef Faridvand, Vahid Toupchi Khosroshahi, Somayeh Sarvari","doi":"10.1515/hmbci-2023-0072","DOIUrl":"https://doi.org/10.1515/hmbci-2023-0072","url":null,"abstract":"<p><strong>Objectives: </strong>The acute phase of ST-segment elevation myocardial infarction (STEMI), as determined by TIMI angiographic criteria, is influenced by various factors that impact the patient's clinical outcome. However, the modifiable risk factors of impaired TIMI flow (TIMI<3) and its effective treatment are not fully understood. Hyperglycemia may induce a pro thrombotic state and thus affect TIMI flow before or after PCI. This study investigates the correlation between hemoglobin A1c levels, TIMI flow grade, and thrombus grade in infarct-related arteries, assessing its predictive value in non-diabetic patients with STEMI.</p><p><strong>Methods: </strong>The 265 patients selected based on the hemoglobin A1c level lower than 6.5 % and were divided into three groups based on HbA1c level. Comparison between three groups in terms of risk factors, troponin level, blood glucose level, lipid profile, kidney function, number of involved vessels, type of MI, left ventricular ejection fraction, TIMI flow before and after primary angioplasty, thrombus burden, complications and hospital mortality was made.</p><p><strong>Results: </strong>With the increase in HbA1c level, the prevalence of TIMI 3 flow after primary PCI decreased. The prevalence of TIMI flow 2-3 before angioplasty also decreased with the increase in HbA1c level. Increased hemoglobin A1c was also significantly related to large thrombus burden (p=0.021). Morover, hemoglobin A1c remained an independent predictor of post-PCI TIMI flow and thrombus burden.</p><p><strong>Conclusions: </strong>Elevated hemoglobin A1c is a predictor of TIMI flow less than 3 after primary PCI and high thrombus burden, in STEMI patients without a history of diabetes mellitus.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142286066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling bisphenol A toxicity: human health impacts and sustainable treatment strategies. 揭示双酚 A 的毒性:对人类健康的影响和可持续处理战略。
IF 1.1 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-09-24 DOI: 10.1515/hmbci-2024-0034
Krishnendu Adhikary, Shweta Kumari, Prity Chatterjee, Riya Dey, Rajkumar Maiti, Sankha Chakrabortty, Deepika Ahuja, Prithviraj Karak

Introduction: The widespread presence of bisphenol-A (BPA) in consumer goods like water bottles and eyeglass frames raises serious concerns about the chemical's ability to accumulate in human tissues. Molecular filtration and activated carbon adsorption are two of the many BPA treatment technologies that have emerged in response to these issues; both are essential in the removal or degradation of BPA from water sources and industrial effluents.

Content: To secure the long-term health and environmental advantages of BPA treatment approaches, sustainable development is essential. Both the efficient elimination or destruction of BPA and the reduction of the treatment operations' impact on the environment are important components of a sustainable approach. Different search engines like Pub-Med, MEDLINE, Google Scholar and Scopus are used for these systematic reviews and analyzed accordingly. This can be accomplished by making treatment facilities more energy efficient and using environmentally friendly materials. Greener ways to deal with BPA pollution are on the horizon, thanks to innovative techniques like bioremediation and improved oxidation processes. Reducing dependence on conventional, resource-intensive procedures can be achieved by investigating the use of bio-based materials and natural adsorbents in treatment processes.

Summary and outlook: This review article tackling the health and environmental concerns raised by BPA calls for an integrated strategy that incorporates sustainable development principles and technology progress. We can reduce the negative impacts of BPA contamination, improve environmental stewardship in the long run, and ensure human health by combining cutting-edge treatment technologies with sustainable behaviours.

导言:双酚-A(BPA)广泛存在于水瓶和眼镜框等消费品中,引起了人们对这种化学物质在人体组织中蓄积能力的严重担忧。分子过滤和活性炭吸附是为应对这些问题而出现的众多双酚 A 处理技术中的两种;这两种技术对于去除或降解水源和工业废水中的双酚 A 至关重要:为了确保双酚 A 处理方法在健康和环境方面的长期优势,可持续发展至关重要。有效消除或销毁双酚 A 和减少处理操作对环境的影响是可持续发展方法的重要组成部分。我们使用 Pub-Med、MEDLINE、Google Scholar 和 Scopus 等不同的搜索引擎对这些系统性综述进行相应的分析。这可以通过提高处理设施的能效和使用环保材料来实现。由于采用了生物修复和改进氧化工艺等创新技术,处理双酚 A 污染的更环保方法即将问世。通过研究在处理过程中使用生物基材料和天然吸附剂,可以减少对传统的资源密集型程序的依赖:这篇综述文章探讨了双酚 A 引起的健康和环境问题,呼吁采取综合战略,将可持续发展原则和技术进步结合起来。通过将尖端处理技术与可持续行为相结合,我们可以减少双酚 A 污染的负面影响,从长远角度改善环境管理,并确保人类健康。
{"title":"Unveiling bisphenol A toxicity: human health impacts and sustainable treatment strategies.","authors":"Krishnendu Adhikary, Shweta Kumari, Prity Chatterjee, Riya Dey, Rajkumar Maiti, Sankha Chakrabortty, Deepika Ahuja, Prithviraj Karak","doi":"10.1515/hmbci-2024-0034","DOIUrl":"https://doi.org/10.1515/hmbci-2024-0034","url":null,"abstract":"<p><strong>Introduction: </strong>The widespread presence of bisphenol-A (BPA) in consumer goods like water bottles and eyeglass frames raises serious concerns about the chemical's ability to accumulate in human tissues. Molecular filtration and activated carbon adsorption are two of the many BPA treatment technologies that have emerged in response to these issues; both are essential in the removal or degradation of BPA from water sources and industrial effluents.</p><p><strong>Content: </strong>To secure the long-term health and environmental advantages of BPA treatment approaches, sustainable development is essential. Both the efficient elimination or destruction of BPA and the reduction of the treatment operations' impact on the environment are important components of a sustainable approach. Different search engines like Pub-Med, MEDLINE, Google Scholar and Scopus are used for these systematic reviews and analyzed accordingly. This can be accomplished by making treatment facilities more energy efficient and using environmentally friendly materials. Greener ways to deal with BPA pollution are on the horizon, thanks to innovative techniques like bioremediation and improved oxidation processes. Reducing dependence on conventional, resource-intensive procedures can be achieved by investigating the use of bio-based materials and natural adsorbents in treatment processes.</p><p><strong>Summary and outlook: </strong>This review article tackling the health and environmental concerns raised by BPA calls for an integrated strategy that incorporates sustainable development principles and technology progress. We can reduce the negative impacts of BPA contamination, improve environmental stewardship in the long run, and ensure human health by combining cutting-edge treatment technologies with sustainable behaviours.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142286067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the effect of taurine on the matrix metalloproteinase-9 and the expression changes of miRNA-21 and miRNA-146a in SH-SY5Y cell line. 评估牛磺酸对基质金属蛋白酶-9的影响以及miRNA-21和miRNA-146a在SH-SY5Y细胞系中的表达变化。
IF 1.1 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-09-16 DOI: 10.1515/hmbci-2024-0005
Abduladheem Al-Attabi, Bilal Abdulmajeed Mukhlif, Karrar R Al-Shami, Muna S Merza, Sami Awad Alkubaisy, Mohanad Ali Abdulhadi

Objectives: Alzheimer's disease (AD), a brain disorder, is the leading cause of dementia among older adults. Taurine, an amino acid abundantly present in the brain, and shows potential neuroprotective properties. Therefore, we investigated the effects of taurine on Matrix Metalloproteinase-9 (MMP-9) levels and the expression changes of miRNA-21 and miRNA-146a in the SH-SY5Y cell line.

Methods: Taurine's impact on the SH-SY5Y cell line was evaluated via the 2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. MMP-9 levels were measured using an enzyme-linked immunosorbent assay (ELISA) kit, while the expression of miRNA-21 and miRNA-146a genes was assessed through Real-Time PCR analysis.

Results: The MTT assay revealed no toxic effects on SH-SY5Y cells with increasing concentrations of taurine. Analysis of gene expression indicated a rise in miRNA-21 expression and a decline in miRNA-146 expression with increasing taurine concentration, with the most notable change observed at 1 mg/mL taurine (p<0.001). ELISA results demonstrated a significant increase in MMP-9 levels in the SH-SY5Y cell line treated with 1 mg/mL taurine compared to the untreated group (p<0.001).

Conclusions: Our study revealed that taurine can alter the expression of miRNA-146a and miRNA-21. In conclusion, taurine therapy presents promising therapeutic avenues for treating AD or mitigating severe symptoms. Nonetheless, further research is necessary to comprehensively grasp the precise mechanisms at play.

目标:阿尔茨海默病(AD)是一种脑部疾病,是导致老年人痴呆的主要原因。牛磺酸是一种在大脑中含量丰富的氨基酸,具有潜在的神经保护特性。因此,我们研究了牛磺酸对基质金属蛋白酶-9(MMP-9)水平的影响,以及 miRNA-21 和 miRNA-146a 在 SH-SY5Y 细胞系中的表达变化:方法:牛磺酸对SH-SY5Y细胞系的影响通过2,5-二苯基-2H-溴化四氮唑(MTT)试验进行评估。使用酶联免疫吸附试验(ELISA)试剂盒测定了 MMP-9 的水平,并通过实时 PCR 分析评估了 miRNA-21 和 miRNA-146a 基因的表达:结果:MTT 试验表明,随着牛磺酸浓度的增加,SH-SY5Y 细胞不会受到毒性影响。基因表达分析表明,随着牛磺酸浓度的增加,miRNA-21 的表达上升,miRNA-146 的表达下降,在 1 mg/mL 牛磺酸浓度下观察到的变化最为显著(p结论:我们的研究表明,牛磺酸能改变 miRNA-146a 和 miRNA-21 的表达。总之,牛磺酸疗法为治疗注意力缺失症或减轻严重症状提供了有希望的治疗途径。然而,要全面掌握其确切的作用机制,还需要进一步的研究。
{"title":"Evaluation of the effect of taurine on the matrix metalloproteinase-9 and the expression changes of miRNA-21 and miRNA-146a in SH-SY5Y cell line.","authors":"Abduladheem Al-Attabi, Bilal Abdulmajeed Mukhlif, Karrar R Al-Shami, Muna S Merza, Sami Awad Alkubaisy, Mohanad Ali Abdulhadi","doi":"10.1515/hmbci-2024-0005","DOIUrl":"https://doi.org/10.1515/hmbci-2024-0005","url":null,"abstract":"<p><strong>Objectives: </strong>Alzheimer's disease (AD), a brain disorder, is the leading cause of dementia among older adults. Taurine, an amino acid abundantly present in the brain, and shows potential neuroprotective properties. Therefore, we investigated the effects of taurine on Matrix Metalloproteinase-9 (MMP-9) levels and the expression changes of miRNA-21 and miRNA-146a in the SH-SY5Y cell line.</p><p><strong>Methods: </strong>Taurine's impact on the SH-SY5Y cell line was evaluated via the 2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. MMP-9 levels were measured using an enzyme-linked immunosorbent assay (ELISA) kit, while the expression of miRNA-21 and miRNA-146a genes was assessed through Real-Time PCR analysis.</p><p><strong>Results: </strong>The MTT assay revealed no toxic effects on SH-SY5Y cells with increasing concentrations of taurine. Analysis of gene expression indicated a rise in miRNA-21 expression and a decline in miRNA-146 expression with increasing taurine concentration, with the most notable change observed at 1 mg/mL taurine (p<0.001). ELISA results demonstrated a significant increase in MMP-9 levels in the SH-SY5Y cell line treated with 1 mg/mL taurine compared to the untreated group (p<0.001).</p><p><strong>Conclusions: </strong>Our study revealed that taurine can alter the expression of miRNA-146a and miRNA-21. In conclusion, taurine therapy presents promising therapeutic avenues for treating AD or mitigating severe symptoms. Nonetheless, further research is necessary to comprehensively grasp the precise mechanisms at play.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142286065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing ICSI outcomes in women with PCOS: the influence of BMI, hormonal levels, and male fertility parameters. 优化多囊卵巢综合征妇女的卵胞浆内单精子显微注射(ICSI)结果:体重指数(BMI)、荷尔蒙水平和男性生育能力参数的影响。
IF 1.1 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-09-04 DOI: 10.1515/hmbci-2024-0035
Muhjah Falah Hassan, Hind Abdul Kadim, Rabab Zahir Al-Yasiry, Sahbaa Hafedh Sagban, Sulagna Dutta, Pallav Sengupta

Objectives: Women with PCOS often experience significant difficulties in achieving spontaneous pregnancy. Intracytoplasmic sperm injection (ICSI) is a viable treatment option for these patients, offering an acceptable success rate. This study purposes to identify factors that may positively or negatively influence pregnancy rates in PCOS women undergoing ICSI and explore potential modifications to enhance successful pregnancy outcomes.

Methods: The study included ninety sub-fertile couples with female partners with diagnosed PCOS. Comprehensive evaluations of the partners included medical history, physical examination, hormonal analysis, transvaginal ultrasound (TVUS), and seminal fluid analysis. All couples underwent ICSI. Pregnancy rates were determined by positive pregnancy tests 14 days after fresh embryo transfer, and participants were divided into two groups: pregnant and non-pregnant.

Results: Of the 90 women who underwent ICSI cycles, 24 achieved pregnancies, resulting in a pregnancy rate of 26.66 %. Non-pregnant women had significantly higher body mass indices (BMI). Additionally, women with elevated cycle day 2 serum estradiol (E2) levels and low follicle-stimulating hormone (FSH) levels exhibited significantly lower pregnancy rates. Women whose male partners had abnormal semen parameters also demonstrated significantly lower pregnancy rates.

Conclusions: Several factors negatively impact pregnancy rates in PCOS women undergoing ICSI, including high BMI, elevated E2, low FSH levels on cycle day 2, a lower number of mature oocytes, and male factor sub-fertility. Many of these factors can be mitigated through the use of ICSI, thereby improving the chances of achieving a successful pregnancy.

目的:患有多囊卵巢综合症的妇女通常很难自然怀孕。卵胞浆内单精子显微注射(ICSI)是一种可行的治疗方法,其成功率可以接受。本研究旨在确定可能对接受卵胞浆内单精子显微注射(ICSI)的多囊卵巢综合征(PCOS)妇女的妊娠率产生积极或消极影响的因素,并探索提高成功妊娠率的潜在方法:研究对象包括九十对亚不育夫妇,其女性伴侣均确诊患有多囊卵巢综合症。夫妻双方的综合评估包括病史、体格检查、激素分析、经阴道超声波(TVUS)和精液分析。所有夫妇都接受了卵胞浆内单精子显微注射(ICSI)。妊娠率通过新鲜胚胎移植 14 天后的阳性妊娠试验来确定,参与者被分为两组:妊娠组和未妊娠组:结果:在接受了卵胞浆内单精子显微注射周期的 90 名女性中,有 24 人成功怀孕,怀孕率为 26.66%。未怀孕妇女的体重指数(BMI)明显较高。此外,周期第 2 天血清雌二醇(E2)水平升高和卵泡刺激素(FSH)水平较低的女性怀孕率明显较低。男性伴侣精液参数异常的女性怀孕率也明显较低:有几个因素对接受卵胞浆内单精子显微注射的多囊卵巢综合征妇女的妊娠率产生了负面影响,包括高体重指数(BMI)、E2 升高、周期第 2 天 FSH 水平低、成熟卵母细胞数量少以及男性因素不育。其中很多因素都可以通过采用卵胞浆内单精子显微注射来缓解,从而提高成功怀孕的几率。
{"title":"Optimizing ICSI outcomes in women with PCOS: the influence of BMI, hormonal levels, and male fertility parameters.","authors":"Muhjah Falah Hassan, Hind Abdul Kadim, Rabab Zahir Al-Yasiry, Sahbaa Hafedh Sagban, Sulagna Dutta, Pallav Sengupta","doi":"10.1515/hmbci-2024-0035","DOIUrl":"https://doi.org/10.1515/hmbci-2024-0035","url":null,"abstract":"<p><strong>Objectives: </strong>Women with PCOS often experience significant difficulties in achieving spontaneous pregnancy. Intracytoplasmic sperm injection (ICSI) is a viable treatment option for these patients, offering an acceptable success rate. This study purposes to identify factors that may positively or negatively influence pregnancy rates in PCOS women undergoing ICSI and explore potential modifications to enhance successful pregnancy outcomes.</p><p><strong>Methods: </strong>The study included ninety sub-fertile couples with female partners with diagnosed PCOS. Comprehensive evaluations of the partners included medical history, physical examination, hormonal analysis, transvaginal ultrasound (TVUS), and seminal fluid analysis. All couples underwent ICSI. Pregnancy rates were determined by positive pregnancy tests 14 days after fresh embryo transfer, and participants were divided into two groups: pregnant and non-pregnant.</p><p><strong>Results: </strong>Of the 90 women who underwent ICSI cycles, 24 achieved pregnancies, resulting in a pregnancy rate of 26.66 %. Non-pregnant women had significantly higher body mass indices (BMI). Additionally, women with elevated cycle day 2 serum estradiol (E2) levels and low follicle-stimulating hormone (FSH) levels exhibited significantly lower pregnancy rates. Women whose male partners had abnormal semen parameters also demonstrated significantly lower pregnancy rates.</p><p><strong>Conclusions: </strong>Several factors negatively impact pregnancy rates in PCOS women undergoing ICSI, including high BMI, elevated E2, low FSH levels on cycle day 2, a lower number of mature oocytes, and male factor sub-fertility. Many of these factors can be mitigated through the use of ICSI, thereby improving the chances of achieving a successful pregnancy.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navigating the challenges: exploring the association between COVID-19 lockdowns and eating behavior in university students: a systematic review and investigation of factors impacting ed levels. 迎接挑战:探索 COVID-19 封锁与大学生饮食行为之间的关联:系统性回顾和影响 ed 水平的因素调查。
IF 1.1 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-08-14 DOI: 10.1515/hmbci-2023-0049
Atul Kumar Sharma, Kapilaanjan Jain, Kratika Mulchandani, Smita R Sorte, Sachin B Rathod, Vinu Vij, Jyotsna Gumashta

Introduction: The COVID-19 pandemic has significantly impacted the mental and physical well-being of individuals globally, with university students being particularly susceptible to mental health issues. Factors such as the transition to adulthood, economic hardships, and academic responsibilities, compounded by pandemic-related disruptions like lockdowns and remote learning, have elevated stress levels and altered daily routines. The pandemic has given rise to post-traumatic stress symptoms in certain individuals, including university students which may contribute to the emergence of emotional eating or adopting unhealthy eating patterns as a coping mechanism, leading to excessive consumption or unhealthy dietary choices. This review aims to investigate the influence of COVID-19 restrictions on eating disorders among university students and identifying the contributing factors.

Content: Out of 59 identified articles, 10 met the inclusion criteria, involving 23,542 participants (70.2 % women, 29.35 % men, 0.42 % gender fluid/undisclosed). The lockdown led to increased prevalence and severity of eating disorders among university students, particularly in women.

Summary: The review highlights a notable increase in eating disorders among university students during the COVID-19 pandemic. Mental health issues, reduced physical activity, and economic stress were significant contributors to this trend, with women being disproportionately affected.

Outlook: To mitigate the impact of future pandemics or similar disruptions, universities should implement early screening, provide mental health counseling, virtual support groups, nutritional guidance, and opportunities for physical activity. Encouraging students to seek professional help is crucial for managing mental health and eating habits in such scenarios.

简介COVID-19 大流行严重影响了全球个人的身心健康,大学生尤其容易受到心理健康问题的影响。成年过渡期、经济困难和学业责任等因素,再加上与大流行相关的停课和远程学习等干扰因素,导致压力水平升高并改变了日常生活。疫情在某些人(包括大学生)身上引发了创伤后应激症状,这可能会导致出现情绪化饮食或采用不健康的饮食模式作为应对机制,从而导致过量消费或选择不健康的饮食。本综述旨在研究 COVID-19 限制对大学生饮食失调的影响,并找出其诱因:在59篇已确定的文章中,有10篇符合纳入标准,涉及23542名参与者(70.2%为女性,29.35%为男性,0.42%为性别不固定/未公开者)。封锁导致大学生饮食失调的发生率和严重程度增加,尤其是女性。摘要:该综述强调,在 COVID-19 大流行期间,大学生饮食失调明显增加。心理健康问题、体育锻炼减少和经济压力是造成这一趋势的重要原因,而女性受到的影响尤为严重:为了减轻未来流行病或类似疾病的影响,大学应实施早期筛查,提供心理健康咨询、虚拟支持小组、营养指导和体育锻炼机会。在这种情况下,鼓励学生寻求专业帮助对于管理心理健康和饮食习惯至关重要。
{"title":"Navigating the challenges: exploring the association between COVID-19 lockdowns and eating behavior in university students: a systematic review and investigation of factors impacting ed levels.","authors":"Atul Kumar Sharma, Kapilaanjan Jain, Kratika Mulchandani, Smita R Sorte, Sachin B Rathod, Vinu Vij, Jyotsna Gumashta","doi":"10.1515/hmbci-2023-0049","DOIUrl":"https://doi.org/10.1515/hmbci-2023-0049","url":null,"abstract":"<p><strong>Introduction: </strong>The COVID-19 pandemic has significantly impacted the mental and physical well-being of individuals globally, with university students being particularly susceptible to mental health issues. Factors such as the transition to adulthood, economic hardships, and academic responsibilities, compounded by pandemic-related disruptions like lockdowns and remote learning, have elevated stress levels and altered daily routines. The pandemic has given rise to post-traumatic stress symptoms in certain individuals, including university students which may contribute to the emergence of emotional eating or adopting unhealthy eating patterns as a coping mechanism, leading to excessive consumption or unhealthy dietary choices. This review aims to investigate the influence of COVID-19 restrictions on eating disorders among university students and identifying the contributing factors.</p><p><strong>Content: </strong>Out of 59 identified articles, 10 met the inclusion criteria, involving 23,542 participants (70.2 % women, 29.35 % men, 0.42 % gender fluid/undisclosed). The lockdown led to increased prevalence and severity of eating disorders among university students, particularly in women.</p><p><strong>Summary: </strong>The review highlights a notable increase in eating disorders among university students during the COVID-19 pandemic. Mental health issues, reduced physical activity, and economic stress were significant contributors to this trend, with women being disproportionately affected.</p><p><strong>Outlook: </strong>To mitigate the impact of future pandemics or similar disruptions, universities should implement early screening, provide mental health counseling, virtual support groups, nutritional guidance, and opportunities for physical activity. Encouraging students to seek professional help is crucial for managing mental health and eating habits in such scenarios.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141975606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The spectrum of clinical, hormonal findings in children with congenital adrenal hyperplasia in Isfahan province; a 20-year review. 伊斯法罕省先天性肾上腺皮质增生症患儿的临床和激素检查结果;20 年回顾。
IF 1.1 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-08-14 DOI: 10.1515/hmbci-2022-0116
Mahin Hashemipour, Rana Saleh

Objectives: Congenital adrenal hyperplasia is an autosomal recessive disorder caused by complete or partial defects in one of the several steroidogenic enzymes involved in synthesizing of cortisol from cholesterol in the adrenal gland. Prompt and proper treatment of the disease would reduce symptoms and the level of androgens in patients. The present study aimed to evaluate the demographic characteristics and clinical findings of these patients.

Methods: This retrospective investigation was conducted in 146 patients with congenital adrenal hyperplasia participated. Their clinical and paraclinical findings were accurately recorded in the file and extracted from the records.

Results: Among all 146 patients, 119(81.5 %) was 21-OH Deficiency type;11-OH Deficiency type was 13(8.9 %), 10(6.8 %) was 3β-HSD type, StAR was 2(1.4 %) and 17 alpha(α)-hydroxylase Deficiency was 2(1.4 %). The mean age of disease onset in these patients was 2.45 ± 1.16 years. Macropenis was the most frequent clinical finding in 39 cases of 64 boys (60.9 %), and Clitoromgaly was the most clinical presentation in 40 cases of 82 girls (48.7 %). The levels of testosterone, dehydroepiandrosterone sulfate, and 17-OHP significantly decreased in the last visit compared to the initial diagnosis.

Conclusions: Based on the clinical findings in every infant or child with ambiguous genitalia, macropenis, clitoromegaly, hirsutism, and premature pubarche, we should consider congenital adrenal hyperplasia. Prompt and proper treatment and disease control would reduce symptoms and the level of androgens in patients.

目标:先天性肾上腺皮质增生症是一种常染色体隐性遗传疾病:先天性肾上腺皮质增生症是一种常染色体隐性遗传疾病,是由于肾上腺内参与从胆固醇合成皮质醇的几种类固醇生成酶中的一种完全或部分缺陷所致。对该病进行及时和适当的治疗可减轻患者的症状和雄激素水平。本研究旨在评估这些患者的人口统计学特征和临床发现:本研究对 146 名先天性肾上腺皮质增生症患者进行了回顾性调查。结果:146 名先天性肾上腺皮质增生症患者中,119 人(占总人数的 11.5%)患有先天性肾上腺皮质增生症:在所有146例患者中,119例(81.5%)为21-OH缺乏型,13例(8.9%)为11-OH缺乏型,10例(6.8%)为3β-HSD型,2例(1.4%)为StAR型,2例(1.4%)为17α-羟化酶缺乏型。这些患者的平均发病年龄为(2.45 ± 1.16)岁。在64名男孩中,39例(60.9%)最常见的临床表现是巨阴茎;在82名女孩中,40例(48.7%)最常见的临床表现是阴蒂畸形。最后一次就诊时,睾酮、硫酸脱氢表雄酮和 17-OHP 的水平与最初诊断时相比明显下降:根据临床表现,如果每个婴儿或儿童都有生殖器不明显、大阴茎、阴蒂肥大、多毛和过早出现青春期,我们就应该考虑先天性肾上腺皮质增生症。及时、正确的治疗和疾病控制可以减轻患者的症状,降低雄激素水平。
{"title":"The spectrum of clinical, hormonal findings in children with congenital adrenal hyperplasia in Isfahan province; a 20-year review.","authors":"Mahin Hashemipour, Rana Saleh","doi":"10.1515/hmbci-2022-0116","DOIUrl":"https://doi.org/10.1515/hmbci-2022-0116","url":null,"abstract":"<p><strong>Objectives: </strong>Congenital adrenal hyperplasia is an autosomal recessive disorder caused by complete or partial defects in one of the several steroidogenic enzymes involved in synthesizing of cortisol from cholesterol in the adrenal gland. Prompt and proper treatment of the disease would reduce symptoms and the level of androgens in patients. The present study aimed to evaluate the demographic characteristics and clinical findings of these patients.</p><p><strong>Methods: </strong>This retrospective investigation was conducted in 146 patients with congenital adrenal hyperplasia participated. Their clinical and paraclinical findings were accurately recorded in the file and extracted from the records.</p><p><strong>Results: </strong>Among all 146 patients, 119(81.5 %) was 21-OH Deficiency type;11-OH Deficiency type was 13(8.9 %), 10(6.8 %) was 3β-HSD type, StAR was 2(1.4 %) and 17 alpha(α)-hydroxylase Deficiency was 2(1.4 %). The mean age of disease onset in these patients was 2.45 ± 1.16 years. Macropenis was the most frequent clinical finding in 39 cases of 64 boys (60.9 %), and Clitoromgaly was the most clinical presentation in 40 cases of 82 girls (48.7 %). The levels of testosterone, dehydroepiandrosterone sulfate, and 17-OHP significantly decreased in the last visit compared to the initial diagnosis.</p><p><strong>Conclusions: </strong>Based on the clinical findings in every infant or child with ambiguous genitalia, macropenis, clitoromegaly, hirsutism, and premature pubarche, we should consider congenital adrenal hyperplasia. Prompt and proper treatment and disease control would reduce symptoms and the level of androgens in patients.</p>","PeriodicalId":13224,"journal":{"name":"Hormone Molecular Biology and Clinical Investigation","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141975607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hormone Molecular Biology and Clinical Investigation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1